救治1例重症原发免疫性血小板减少症患者的病例报道  

A Case Report of Treating a Patient with Severe Primary Immune Thrombocytopenia

作　　者：田明 陈鸣 朱可嘉 金磊[2] 李静娴 

机构地区：[1]中国人民解放军95829部队医院肾内科,湖北 武汉 [2]中国人民解放军95848部队卫生连,湖北 武汉 [3]武汉市武昌区黄鹤楼社区卫生服务中心,湖北 武汉

出　　处：《临床医学进展》2024年第8期1262-1267,共6页Advances in Clinical Medicine

摘　　要：原发免疫性血小板减少症(primary immune thrombocytopenia, ITP)是一种以免疫介导的血小板减少性疾病,该病出血风险性高,尤其是致命性颅内出血,重症患者积极准确诊治可以帮助患者度过危险期。本文旨在报道我科的一名重症ITP患者的救治过程,总结该患者的病历资料,并对ITP的发病机制及治疗方法进行探讨。Primary immune thrombocytopenia (ITP) is an immune-mediated thrombocytopenia disease, which has a high risk of bleeding, especially fatal intracranial hemorrhage. Active and accurate diagnosis and treatment of severe patients can help them overcome the critical period. The purpose of this paper is to report the treatment process of a severe ITP patient in our department, summarize the patient’s medical history, and discuss the pathogenesis and treatment of ITP.

关 键 词：原发免疫性血小板减少症 免疫球蛋白 重组人血小板生成素 海曲泊帕 病例报道 

分 类 号：R55[医药卫生—血液循环系统疾病]